Alaska Chapter of the American College of Cardiology

Rivaroxaban Beyond 6 Weeks: Enhancing Outcomes in Isolated Distal Deep Vein Thrombosis
The optimal management of isolated, distal deep vein thrombosis (DVT) remains unclear. Data from recent studies suggest that certain patients may benefit from anticoagulation...
Pregnancy in Adult Congenital Heart Disease
The prevalence of congenital heart disease (CHD) in pregnancy increased by >30% during the 2010s. CHD is now present in approximately 8:10,000 pregnant persons.
ACCEL Lite: SUMMIT Trial: Tirzepatide for Heart Failure, Preserved Ejection Fraction and Obesity
In this interview, Drs. Alison Bailey and Milton Packer examine the power of tirzepatide expanding beyond weight loss and treating diabetes in addition to reducing heart failure events in patients with obesity-related HFpEF.
LAAO Registry: Racial Disparities in LAAO Use and Outcomes at 1 Year
Among patients undergoing left atrial appendage occlusion (LAAO), rates of procedural success were similar across racial and ethnic groups, but Black patients had higher rates of death and bleeding at one year, according to a recent study published in the Journal of the American Heart Association.
State-of-the-Art Review Examines LAAO as Therapy For Stroke Prevention in Patients With AFib
he utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrial fibrillation (AFib) is the focus of a State-of-the-Art Review published Jan. 8 in JACC: Clinical Electrophysiology.